Silver Book Fact

New medicines, or “new chemical entities” accounted for 40% (0.8 years) of the two-year gain in life expectancy seen in 52 countries from 1986-2000.

Lichtenberg F. The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001. National Bureau of Economic Research. June 2003; Working Paper No. 9754. http://www.nber.org/papers/w9754

Reference

Title
The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001
Publication
National Bureau of Economic Research
Publication Date
June 2003
Authors
Lichtenberg F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Avoidable Treatment Expenditures, 2023  
  • Each new drug approved between 1970 and 1991 saves an average of 11,200 life-years in 1991.  
  • Costs That Can Be Avoided, 2003-2023  
  • Medicines in Development for Older Americans, 2008  
  • Delaying the onset of Alzheimer’s disease, innovations that delay disability among the elderly through 2009, and a 25% increase in efficiency and effectiveness of cancer treatment would save $138 billion…